Section Arrow
VCYT.NASDAQ
- Veracyte
Quotes are at least 15-min delayed:2025/07/02 06:23 EDT
Last
 27.32
+0.29 (+1.07%)
Day High 
27.74 
Prev. Close
27.03 
1-M High
28.43 
Volume 
1.07M 
Bid
27.31
Ask
28
Day Low
26.585 
Open
26.8 
1-M Low
25.85 
Market Cap 
2.12B 
Currency USD 
P/E 64.36 
%Yield -- 
10-SMA 26.79 
20-SMA 26.98 
50-SMA 28.6 
52-W High 47.3162 
52-W Low 19.73 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
0.42/1.21
Enterprise Value
2.16B
Balance Sheet
Book Value Per Share
15.26
Cash Flow
Cash Flow Yield
0.04
Income Statement
Total Revenue
445.76M
Operating Revenue Per Share
4.38
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
NEOGNeogen Corp5.08+0.3+6.28%879PE
DHRDanaher Corp201.1+3.56+1.80%38.28PE
ILMNIllumina98.15+2.74+2.87%-- 
EXASExact Sciences Corp54.6+1.46+2.75%-- 
TMOThermo Fisher Scientific421.47+16.01+3.95%23.46PE
Quotes are at least 15-min delayed:2025/07/02 06:23 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Veracyte Inc is a genomic diagnostics company. The group empowers clinicians with the insights necessary to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. It offers tests for prostate cancer (Decipher Prostate), thyroid cancer (Afirma), breast cancer (Prosigna), and bladder cancer (Decipher Bladder). In addition, its Percepta Nasal Swab test is being run in CLIA labs in support of clinical studies.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.